Notes And Other Explanatory Information [Abstract]

Zealand Pharma - Filing #5889383

Concept 2024-01-01 to
2024-12-31
Notes and other explanatory information [abstract]
Disclosure of accrued expenses and other liabilities [text block]
4
Disclosure of auditors' remuneration [text block]
6
Disclosure of authorisation of financial statements [text block]
The
Disclosure of basis of consolidation [text block]
Consolidated
Disclosure of basis of preparation of financial statements [text block]
1
Disclosure of borrowings [text block]
5
Disclosure of changes in accounting policies [text block]
1
Disclosure of collateral [text block]
6
Disclosure of contingent liabilities [text block]
6
Disclosure of cost of sales [text block]
2
Disclosure of credit risk [text block]
Credit
Disclosure of debt instruments [text block]
4
Disclosure of depreciation and amortisation expense [text block]
DKK
Disclosure of derivative financial instruments [text block]
Fair
Disclosure of earnings per share [text block]
2
Disclosure of effect of changes in foreign exchange rates [text block]
Sensitivity
Disclosure of entity's operating segments [text block]
2
Disclosure of events after reporting period [text block]
7
Disclosure of expenses [text block]
2
Disclosure of financial instruments [text block]
4
Disclosure of general and administrative expense [text block]
3
Disclosure of general information about financial statements [text block]
Accounting
Disclosure of going concern [text block]
Going
Disclosure of impairment of assets [text block]
DKK
Disclosure of income tax [text block]
5
Disclosure of information about employees [text block]
3
Disclosure of information about key management personnel [text block]
5
Disclosure of intangible assets [text block]
3
Disclosure of interest expense [text block]
5
Disclosure of inventories [text block]
4
Disclosure of investments other than investments accounted for using equity method [text block]
3
Disclosure of issued capital [text block]
5
Disclosure of leases [text block]
3
Disclosure of liquidity risk [text block]
Liquidity
Disclosure of market risk [text block]
Exchange
Disclosure of objectives, policies and processes for managing capital [text block]
4
Disclosure of other current liabilities [text block]
3
Disclosure of other non-current assets [text block]
4
Disclosure of other operating expense [text block]
3
Disclosure of prepayments and other assets [text block]
4
Disclosure of property, plant and equipment [text block]
3
Disclosure of related party [text block]
6
Disclosure of research and development expense [text block]
2
Disclosure of restricted cash and cash equivalents [text block]
4
Disclosure of revenue from contracts with customers [text block]
2
Disclosure of trade and other receivables [text block]
4
Disclosure of treasury shares [text block]
Treasury

Talk to a Data Expert

Have a question? We'll get back to you promptly.